TrialClinical rheumatology2024

Efficacy and safety of tocilizumab in Chinese patients with systemic juvenile idiopathic arthritis: a multicentre phase IV trial.

Caifeng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.